Related references
Note: Only part of the references are listed.Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes
Kayo Kuroyanagi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
P. Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Peroxisome proliferator-activated receptor-γ-mediated effects in the vasculature
Sheng Zhong Duan et al.
CIRCULATION RESEARCH (2008)
Endocannabinoids, blood pressure and the human heart
R. Sarzani
JOURNAL OF NEUROENDOCRINOLOGY (2008)
The role of the endocannabinoid system in atherosclerosis
F. Mach et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages
Miyuki Yano et al.
CIRCULATION RESEARCH (2007)
A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-γ activity
Michael Schupp et al.
MOLECULAR PHARMACOLOGY (2007)
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake
V. Gasperi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Cannabinoids and PPARα signalling
Y. Sun et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation
Juergen Janke et al.
JOURNAL OF HYPERTENSION (2006)
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor γ independently of cannabinoid receptors 1 and 2
Cheryl E. Rockwell et al.
MOLECULAR PHARMACOLOGY (2006)
Further characterization of the time-dependent vascular effects of Δ9-tetrahydrocannabinol
SE O'Sullivan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor
PM Hoi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O'Sullivan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism
NJ Underdown et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Pioglitazone, a PPARγ agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats
JB Majithiya et al.
CARDIOVASCULAR RESEARCH (2005)
Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production
JN Hwang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Vascular effects of Δ9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta
SE O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes
Z Bagi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Peroxisome proliferator-activated receptor γ:: Implications for cardiovascular disease
WA Hsueh et al.
HYPERTENSION (2004)
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone -: Evidence for involvement of peroxisome proliferator-activated receptor (PPAR)γ-dependent and PPARγ-independent signaling pathways
DH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α)
M Guzmán et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes
CE Rockwell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
The complexities of the cardiovascular actions of cannabinoids
MD Randall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
Activation and binding of peroxisome proliferator-activated receptor γ by synthetic cannabinoid ajulemic acid
JL Liu et al.
MOLECULAR PHARMACOLOGY (2003)
Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line
BL Upham et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor
L Offertáler et al.
MOLECULAR PHARMACOLOGY (2003)
15-lipoxygenase metabolism of 2-arachidonylglycerol -: Generation of a peroxisome proliferator-activated receptor α agonist
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed
D Harris et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Peroxisome proliferator-activated receptors in the cardiovascular system
D Bishop-Bailey
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
